Therefore, this study aims to explore the bioregulation of miR-148-3p in GC, the molecular mechanism of miR-148-3p/Bcl-2 in GC and drug resistance, to lay a theoretical foundation for drug development and possible clinical application in the future. This evidence concerns the gene BCL2 and gastric cancer.